BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11032062)

  • 1. Treatment of recalcitrant ulcers in pyoderma gangrenosum with mycophenolate mofetil and autologous keratinocyte transplantation on a hyaluronic acid matrix.
    Wollina U; Karamfilov T
    J Eur Acad Dermatol Venereol; 2000 May; 14(3):187-90. PubMed ID: 11032062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe recalcitrant pyoderma gangrenosum responding to a combination of mycophenolate mofetil with cyclosporin and complicated by a mononeuritis.
    Gilmour E; Stewart DG
    Br J Dermatol; 2001 Feb; 144(2):397-400. PubMed ID: 11251582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycophenolate mofetil as therapy for pyoderma gangrenosum.
    Eaton PA; Callen JP
    Arch Dermatol; 2009 Jul; 145(7):781-5. PubMed ID: 19620559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycophenolate mofetil and cyclosporin treatment for recalcitrant pyoderma gangrenosum.
    Hohenleutner U; Mohr VD; Michel S; Landthaler M
    Lancet; 1997 Dec; 350(9093):1748. PubMed ID: 9413469
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapy-resistant pyoderma gangrenosum--treatment with mycophenolate mofetil and cyclosporine A].
    Michel S; Hohenleutner U; Mohr V; Landthaler M
    Hautarzt; 1999 Jun; 50(6):428-31. PubMed ID: 10427512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effectiveness of mycophenolate mofetil in refractory pyoderma gangrenosum.
    Nousari HC; Lynch W; Anhalt GJ; Petri M
    Arch Dermatol; 1998 Dec; 134(12):1509-11. PubMed ID: 9875186
    [No Abstract]   [Full Text] [Related]  

  • 7. Pyoderma gangrenosum associated with Wegener's granulomatosis: partial response to mycophenolate mofetil.
    Le Hello C; Bonte I; Mora JJ; Verneuil L; Noël LH; Guillevin L
    Rheumatology (Oxford); 2002 Feb; 41(2):236-7. PubMed ID: 11886982
    [No Abstract]   [Full Text] [Related]  

  • 8. Mycophenolate mofetil is an effective treatment for peristomal pyoderma gangrenosum.
    Daniels NH; Callen JP
    Arch Dermatol; 2004 Dec; 140(12):1427-9. PubMed ID: 15611417
    [No Abstract]   [Full Text] [Related]  

  • 9. Mycophenolate mofetil in pyoderma gangrenosum.
    Lee MR; Cooper AJ
    J Dermatolog Treat; 2004 Sep; 15(5):303-7. PubMed ID: 15370398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of epidermolysis bullosa acquisita with mycophenolate mofetil and autologous keratinocyte grafting.
    Schattenkirchner S; Eming S; Hunzelmann N; Krieg T; Smola H
    Br J Dermatol; 1999 Nov; 141(5):932-3. PubMed ID: 10583185
    [No Abstract]   [Full Text] [Related]  

  • 11. Multimodal therapy of idiopathic pyoderma gangrenosum.
    Sharon V; Burrall B; Patel F; He Y; Konia T; Villalobos IB; Maverakis E
    Dermatol Online J; 2014 Jun; 20(6):. PubMed ID: 24945643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycophenolate mofetil as adjunctive therapy to corticosteroids for the treatment of pyoderma gangrenosum: a case series and literature review.
    Hrin ML; Bashyam AM; Huang WW; Feldman SR
    Int J Dermatol; 2021 Dec; 60(12):e486-e492. PubMed ID: 33739458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycophenolate mofetil and skin diseases.
    Hartmann M; Enk A
    Lupus; 2005; 14 Suppl 1():s58-63. PubMed ID: 15803935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical management of pyoderma gangrenosum.
    Wollina U
    Am J Clin Dermatol; 2002; 3(3):149-58. PubMed ID: 11978136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of pyoderma gangrenosum with cultured keratinocyte autografts.
    Límová M; Mauro T
    J Dermatol Surg Oncol; 1994 Dec; 20(12):833-6. PubMed ID: 7798418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refractory postsurgical pyoderma gangrenosum in a patient with Beckwith Wiedemann syndrome: response to multimodal therapy.
    Fakhar F; Memon S; Deitz D; Abramowitz R; Alpert DR
    BMJ Case Rep; 2013 Oct; 2013():. PubMed ID: 24154999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycophenolate use in dermatology: a clinical audit.
    Li J; Chong AH; Green J; Kelly R; Baker C
    Australas J Dermatol; 2013 Nov; 54(4):296-302. PubMed ID: 23574297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of pyoderma gangrenosum with mycophenolate mofetil as a steroid-sparing agent.
    Li J; Kelly R
    J Am Acad Dermatol; 2013 Oct; 69(4):565-9. PubMed ID: 23850090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Extensive ulcerations in children: The difficulty diagnosing pyoderma gangrenosum].
    Ramli I; Rachadi H; Amarouch H; Rimani M; Senouci K; Benzekri L; Hassam B
    Arch Pediatr; 2015 Jul; 22(7):753-5. PubMed ID: 26047747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.